Psychiatric outpatients' self-reported adherence versus psychiatrists' impressions on adherence in affective disorders

Human Psychopharmacology

Volumn 28, Issue 2, 2013, Pages 142-150

  De Las Cuevas, Carlos ^a   Peñate, Wenceslao ^a   Sanz, Emilio J ^a  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

adherence; affective disorders; attitudes; beliefs; concordance; psychiatric outpatients

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; MOOD STABILIZER; NORADRENALIN UPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ASSESSMENT; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DEPRESSION INVENTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; MOOD DISORDER; OUTPATIENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHIATRIC TREATMENT; PSYCHIATRIST; SELF REPORT; TREATMENT DURATION;

ADULT; AGED; AMBULATORY CARE; ATTITUDE OF HEALTH PERSONNEL; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MOOD DISORDERS; PSYCHIATRY; SELF REPORT; YOUNG ADULT;

EID: 84875683033     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.2293     Document Type: Article

References (63)

1. Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, et al,. 2004. Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiat Scand, Suppl 420: 21-27.
2. APA Guideline for Major Depression in Adults, 2nd Edition 2000. Clinical practice guidelines are reviewed at least once every two years. Web sites of nationally recognized sources from which guidelines have been adopted are checked monthly for changes/updates. Original: July 2004. Rev. May 2006.
3. Barbui C, Cipriani A, Patel V, Ayuso-Mateos JL, van Ommeren M,. 2011. Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis. Br J Psychiatry 198 (1): 11-16, sup 1.
4. Beck AT, Steer RA, Ball R, Ranieri W,. 1996. Comparison of Beck Depression Inventories-IA and II in psychiatric outpatients. J Pers Assess 67 (3): 588-597.
5. Beléndez M, Hernández A, Horne R, Weinman J,. 2007. Evaluaciõn de las creencias sobre el tratamiento: validez y fiabilidad de la versiõn española del Beliefs about Medicines Questionnaire. Int J Clin Health Psychol 7: 767-779.
6. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J,. 2002. Long-term persistence in use of statin therapy in elderly patients. JAMA 288: 455-461.
7. Biegler P, (2011) The Ethical Treatment of Depression: Autonomy through Psychotherapy. MIT Press: Cambridge, Mass.
8. Brown C, Battista DR, Bruehlman R, Sereika SS, Thase ME, Dunbar-Jacob J,. 2005. Beliefs about antidepressant medications in primary care patients: relationship to self-reported adherence. Med Care 43 (12): 1203-1207.
9. Cassidy CM, Rabinovitch M, Schmitz N, Joober R, Malla A,. 2010. A comparison study of multiple measures of adherence to antipsychotic medication in first-episode psychosis. J Clin Psychopharmacol 30 (1): 64-67.
10. Chakraborty K, Avasthi A, Kumar S, Grover S,. 2009. Attitudes and beliefs of patients of first episode depression towards antidepressants and their adherence to treatment. Soc Psychiatry Psychiatr Epidemiol 44 (6): 482-488.
11. Chapman RH, Benner JS, Petrilla AA, Tierce JC, Collins SR, Battleman DS,. 2005. Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med 165: 1147-1152.
12. Claxton AJ, Cramer J, Pierce C,. A systematic review of the associations between dose regimens and medication compliance. 2001. Clin Ther 23: 1296-1310.
13. Clayton CD, Veach J, Macfadden W, Haskins J, Docherty JP, Lindenmayer JP,. Assessment of clinician awareness of nonadherence using a new structured rating scale. 2010. J Psychiatr Pract 16 (3): 164-169.
14. De las Cuevas C,. 2011. Towards a clarification of terminology in medicine taking behavior: compliance, adherence and concordance are related although different terms with different uses. Curr Clin Pharmacol 6 (2): 74-77.
15. De las Cuevas C, Sanz EJ,. 2004. Polypharmacy in psychiatric practice in the Canary Islands. BMC Psychiatry 4: 18.
16. De las Cuevas C, Sanz EJ, De la Fuente JA, Cueto M,. 2005, Polypharmacy in psychiatric patients as an alternative to limited mental health resources. Actas Esp Psiquiatr 33 (2): 81-86.
17. De las Cuevas C, Rivero A, Perestelo-Perez L, Gonzalez M, Perez J, Peñate W,. 2011b. Psychiatric patients' attitudes towards concordance and shared decision making. Patient Educ Couns 85: e245-e250.
18. De las Cuevas C, Rivero-Santana A, Perestelo-Pérez L, González-Lorenzo M, Pérez-Ramos J, Sanz EJ,. 2011a. Adaptation and validation study of the Beliefs about Medicines Questionnaire in psychiatric outpatients in a community mental health setting. Hum Psychopharm Clin 26: 140-146.
19. Demyttenaere K,. 1998. Noncompliance with antidepressants:who's to blame? Int Clin Psychopharmacol 13 (Suppl 2): S19-S25.
20. Edlund MJ, Fortney JC, Reaves CM, Pyne JM, Mittal D,. 2008. Beliefs about depression and depression treatment among depressed veterans. Med Care 46 (6): 581-589.
21. Elwyn G, Miron-Shatz T,. 2010. Deliberation before determination: the definition and evaluation of good decision making. Health Expect 13: 139-147.
22. Farmer KC,. 1999. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther 21: 1074-1090.
23. Grant RW, Devita NG, Singer DE,. 2003. Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care 26: 1408-1412.
24. Hansen HV, Kessing LV,. Adherence to antidepressant treatment. Expert Rev Neurother 2007, 7 (1): 57-62.
25. Haynes RB, McDonald H, Garg AX, Montague P., 2002. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev (2).
26. Hill SA, Laugharne R,. 2006. Decision making and information seeking preferences among psychiatric patients. J Ment Health 15: 75-84.
27. Hogan TP, Awad AG,. 1992. Subjective response to neuroleptics and outcome in schizophrenia: a re-examination comparing two measures. Psychol Med 22: 347-352.
28. Hogan TP, Awad AG, Eastwood R,. 1983. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med 13: 177-183.
29. Horne R, Weinman J,. 1999. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illnesss. J Psychosom Res 47: 555-567.
30. Horne R, Weinman J, Hankins M,. 1999. The Beliefs about Medicines Questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 14: 1-24.
31. Horne R, Weinman J, Barber N, Elliott R, Morgan M, Cribb A,. (2005). Concordance, adherence and compliance in medicine taking. Report for the National Coordinating Centre for NHS Service Delivery and Organisation R&D (NCCSDO). National Coordinating Centre for NHS Service Delivery and Organisation Research & Development: London.
32. Iskedjian M, Einarson TR, MacKeigan LD,. 2002. Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis. Clin Ther 24: 302-316.
33. Jõnsdõttir H, Friis S, Horne R, Pettersen KI, Reikvam A, Andreassen OA,. 2009. Beliefs about medications: measurement and relationship to adherence in patients with severe mental disorders. Acta Psychiatr Scand 119 (1): 78-84.
34. Kessler RC, Demler O, Frank RG, Olfson M, Pincus HA, Walters EE, Wang P, Wells KB, Zaslavsky AM,. 2005. Prevalence and treatment of mental disorders, 1990 to 2003. N Engl J Med 352 (24): 2515-2523.
35. Kumar K, Gordon C, Toescu V, Buckley CD, Horne R, Nightingale PG, Raza K,. 2008. Beliefs about medicines in patients with rheumatoid arthritis and systemic lupus erythematosus: a comparison between patients of south Asian and white British origin. Rheumatology 47 (5): 690-697.
36. Lima VD, Harrigan R, Bangsberg DR, Hogg RS, Gross R, Yip B,. 2009. The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time. J Acquir Immune Defic Syndr 50: 529-536.
37. Mahler C, Hermann K, Horne R, Jank S, Haefeli WE, Szecsenyi J,. 2012. Patients' Beliefs about Medicines in a primary care setting in Germany. J Eval Clin Pract 18 (2): 409-413.
38. Manninen BA,. 2006. Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs. J Med Ethics 32 (2): 100-105.
39. Miklowitz DJ, Simoneau TL, George EL, Richards JA, Kalbag A, Sachs-Ericsson N, Suddath R,. 2000. Family-focused treatment of bipolar disorder: 1-year effects of a psychoeducational program in conjunction with pharmacotherapy. Biol Psychiatry 48: 582-592.
40. Morisky DE, Green LW, Levine DM,. 1986. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 24: 67-74.
41. Morisky DE, Ang A, Krousel-Wood M, Ward HJ,. 2008. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) 10: 348-354.
42. Murray M, Kroenke K,. 2001. Polypharmacy and medication adherence: small steps on a long road. J Gen Intern Med 16: 137-139.
43. National Association of State Mental Health Program Directors. 2001. Technical report on psychiatric polypharmacy. Medical Directors Council and State Medicaid Directors Alexandria, Virginia.
44. Osterberg L, Blaschke T,. 2005. Adherence to medication. N Engl J Med, 353: 487-497.
45. Patal RP, Taylor SD,. 2002. Factors affecting medication adherence in hypertensive patients. Ann Pharmacother 36: 40-45.
46. Patel SR, Bakken S,. 2010. Preferences for participation in decision making among ethnically diverse patients with anxiety and depression. Community Ment Health J 46: 466-473.
47. Rascati K,. 1995. Drug utilization review of concomitant use of specific serotonine reuptake inhibitors or clomipramine and antianxiety/sleep medications. Clin Ther 17: 786-790.
48. Raynor DK, Thistlethwaite JE, Hart K, Knapp P,. 2001. Are health professionals ready for the new philosophy of concordance in medicine taking? Int J Pharm Pract 9: 81-84.
49. Robinson JH, Callister IC, Berry JA, Dearing KA,. 2008. Patient-centered care and adherence: definitions and applications to improve outcomes. J Am Acad Nurse Pract 20 (12): 600-607.
50. Russell J, Kazantzis N,. 2008. Medication beliefs and adherence to antidepressants in primary care. N Z Med J 121 (1286): 14-20.
51. Sabaté E,. 2003. Adherence to Long-Term Therapies Evidence for Action World Health Organization: Geneva.
52. Sanz J, García MP, Espinosa R, Fortún M, Vázquez C,. 2005. Adaptaciõn española del Inventario para la Depresiõn de Beck-II (BDI-II): 3. Propiedades psicométricas en pacientes con trastornos psicolõgicos. Clin Salud 16, 121-142.
53. Shalansky SJ, Levy AR, Ignaszewski AP,. 2004. Self-reported Morisky score for identifying nonadherence with cardiovascular medications. Ann Pharmacother 38: 1363-1368.
54. Stahl SM,. 2002. Antipsychotic polypharmacy: squandering precious resources? J Clin Psychiatry 63 (2): 93-94.
55. Tanaka E, Hiswa S,. 1999. Clinically significant pharmacokinetic drug interactions with psychoactive drugs: antidepressants and antipsychotics and the cytochrome P450 system. J Clin Pharm Ther 24: 7-16.
56. Val JA, Amorõs BG, Martínez VP, Fernández Ferre ML, Leõn SM,. 1992. Descriptive study of patient compliance in pharmacologic antihypertensive treatment and validation of the Morisky and Green test. Aten Primaria 10 (5): 767-770.
57. Velligan DI, Lam YW, Glahn DC, Barrett JA, Maples NJ, Ereshefsky L, Miller AL,. 2006. Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophr Bull 32 (4): 724-742.
58. Velligan DI, Wang M, Diamond P, Glahn DC, Castillo D, Bendle S, Lam YW, Ereshefsky L, Miller AL,. 2007. Relationships among subjective and objective measures of adherence to oral antipsychotic medications. Psychiatr Serv 58 (9): 1187-1192.
59. Vermeire E, Hearnshaw H, Van Royen P, Denekens J,. 2001. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther 26 (5): 331-342.
60. Vieta E, Blasco-Colmenares E, Figueira ML, Langosch JM, Moreno-Manzanaro M, Medina E, WAVE-bd Study Group. 2011. Clinical management and burden of bipolar disorder: a multinational longitudinal study (WAVE-bd study). BMC Psychiatry 11: 58.
61. Weich S, Morgan L, King M, Nazareth I,. 2007. Attitudes to depression and its treatment in primary care. Psychol Med 37 (9): 1239-1248.
62. Wilder CM, Elbogen EB, Moser LL, Swanson JW, Swartz MS,. 2010, Medication preferences and adherence among individuals with severe mental illness and psychiatric advance directives. Psychiatr Serv 61 (4): 380-385.
63. World Health Organization. (2003) Investing in Mental Health. World Health Organization: Geneva.